133 related articles for article (PubMed ID: 21296418)
1. Bone marrow fibrosis in myeloproliferative neoplasms-associated myelofibrosis: deconstructing a myth?
Barosi G; Gale RP
Leuk Res; 2011 May; 35(5):563-5. PubMed ID: 21296418
[TBL] [Abstract][Full Text] [Related]
2. Does auto-immunity contribute to anemia in myeloproliferative neoplasms (MPN)-associated myelofibrosis?
Barosi G; Magrini U; Gale RP
Leuk Res; 2010 Sep; 34(9):1119-20. PubMed ID: 20538336
[No Abstract] [Full Text] [Related]
3. Mast cell burden and reticulin fibrosis in the myeloproliferative neoplasms: a computer-assisted image analysis study.
Ahmed A; Powers MP; Youker KA; Rice L; Ewton A; Dunphy CH; Chang CC
Pathol Res Pract; 2009; 205(9):634-8. PubMed ID: 19446406
[TBL] [Abstract][Full Text] [Related]
4. Myelofibrosis revisited: characterization and classification of myelofibrosis in the setting of myeloproliferative disease.
Gilbert HS
Prog Clin Biol Res; 1984; 154():3-17. PubMed ID: 6382299
[TBL] [Abstract][Full Text] [Related]
5. Myelofibrosis in myeloproliferative disorders.
Srinivasan U; Talvalkar GV; Advani SH
Indian J Cancer; 1978 Sep; 15(3):37-43. PubMed ID: 294411
[No Abstract] [Full Text] [Related]
6. Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders.
Sayinalp N; Cinar H; Uner A; Haznedaroğlu IC; Büyükaşik Y; Göker H; Aksu S; Ozcebe OI; Karakuş S; Kirazli S; Dündar SV
Clin Lab Haematol; 2004 Aug; 26(4):265-8. PubMed ID: 15279663
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of myelofibrosis with myeloid metaplasia: Insight from mouse models.
Chagraoui H; Wendling F; Vainchenker W
Best Pract Res Clin Haematol; 2006; 19(3):399-412. PubMed ID: 16781480
[TBL] [Abstract][Full Text] [Related]
8. Increased Dkk3 protein expression in platelets and megakaryocytes of patients with myeloproliferative neoplasms.
Medinger M; Tzankov A; Kern J; Pircher A; Hermann M; Ott HW; Gastl G; Untergasser G; Gunsilius E
Thromb Haemost; 2011 Jan; 105(1):72-80. PubMed ID: 20978717
[TBL] [Abstract][Full Text] [Related]
9. Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN.
Gleitz HFE; Dugourd AJF; Leimkühler NB; Snoeren IAM; Fuchs SNR; Menzel S; Ziegler S; Kröger N; Triviai I; Büsche G; Kreipe H; Banjanin B; Pritchard JE; Hoogenboezem R; Bindels EM; Schumacher N; Rose-John S; Elf S; Saez-Rodriguez J; Kramann R; Schneider RK
Blood; 2020 Oct; 136(18):2051-2064. PubMed ID: 32726410
[TBL] [Abstract][Full Text] [Related]
10. [Bone marrow fibrosis in malignant hemopathies and cancers. Histological study of 2 786 biopsies (author's transl)].
Duhamel G; Stachowiak J
Sem Hop; 1981 Jan 18-25; 57(3-4):111-6. PubMed ID: 6261348
[TBL] [Abstract][Full Text] [Related]
11. [Pathogenesis of marrow fibrosis in myeloproliferative disorders].
Wróbel T; Podolak-Dawidziak M
Pol Arch Med Wewn; 1998 Jan; 99(1):70-7. PubMed ID: 9686507
[No Abstract] [Full Text] [Related]
12. Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): clinicopathologic comparison of del(5q)-positive and -negative cases.
Santana-Davila R; Tefferi A; Holtan SG; Ketterling RP; Dewald GW; Knudson RA; Steensma DP; Chen D; Hoyer JD; Hanson CA
Leuk Res; 2008 Dec; 32(12):1927-30. PubMed ID: 18538839
[TBL] [Abstract][Full Text] [Related]
13. Critical review of pathogenetic mechanisms in myelofibrosis with myeloid metaplasia.
Martyré MC
Curr Hematol Rep; 2003 May; 2(3):257-63. PubMed ID: 12901348
[TBL] [Abstract][Full Text] [Related]
14. Aberrant proplatelet formation in chronic myeloproliferative neoplasms.
Muth M; Büsche G; Bock O; Hussein K; Kreipe H
Leuk Res; 2010 Nov; 34(11):1424-9. PubMed ID: 20430444
[TBL] [Abstract][Full Text] [Related]
15. Properties of myelofibrosis-derived fibroblasts.
Castro-Malaspina H; Jhanwar SC
Prog Clin Biol Res; 1984; 154():307-22. PubMed ID: 6382300
[TBL] [Abstract][Full Text] [Related]
16. Reversal of bone marrow fibrosis and subsequent development of polycythemia in patients with myeloproliferative disorders.
Talarico L; Wolf BC; Kumar A; Weintraub LR
Am J Hematol; 1989 Apr; 30(4):248-53. PubMed ID: 2929585
[TBL] [Abstract][Full Text] [Related]
17. Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis.
Schlenk RF; Stegelmann F; Reiter A; Jost E; Gattermann N; Hebart H; Waller C; Hochhaus A; Platzbecker U; Schafhausen P; Blau IW; Verbeek W; Heidel FH; Werner M; Kreipe H; Teleanu V; Benner A; Döhner H; Grießhammer M; Döhner K
Leukemia; 2017 Apr; 31(4):889-895. PubMed ID: 27774990
[TBL] [Abstract][Full Text] [Related]
18. [Is myeloic metaplasia of the spleen caused by a disorder of immunobiologic functions?].
Kunz G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(6):899-903. PubMed ID: 4141974
[No Abstract] [Full Text] [Related]
19. MPN-associated myelofibrosis (MPN-MF).
Mesa RA; Green A; Barosi G; Verstovsek S; Vardiman J; Gale RP
Leuk Res; 2011 Jan; 35(1):12-3. PubMed ID: 20684988
[No Abstract] [Full Text] [Related]
20. Mechanism of myelofibrosis in chronic myeloproliferative disorders.
Yonekura S
Tokai J Exp Clin Med; 1987 Sep; 12(3):141-5. PubMed ID: 3331217
[No Abstract] [Full Text] [Related]
[Next] [New Search]
